Teri Klein

Teri Klein is a renowned pharmacogenomics researcher and professor at Stanford University. She is best known for her work in the field of pharmacogenetics, which studies how genetic variations influence individual responses to drugs.

Early Life and Education

Teri Klein was born and raised in the United States. She pursued her undergraduate studies in Biology and later earned her Ph.D. in Genetics from a prestigious university.

Career

Klein started her career as a researcher in the field of genetics. Her research primarily focused on understanding the genetic variations that influence the body's response to drugs. She later joined Stanford University as a professor, where she continued her research in pharmacogenomics.

At Stanford, Klein led a team of researchers in the development of PharmGKB, a comprehensive resource that provides information about the impact of genetic variation on drug response. PharmGKB has been instrumental in advancing the field of pharmacogenomics and has been widely used by researchers and clinicians worldwide.

Contributions to Pharmacogenomics

Klein's work in pharmacogenomics has significantly advanced our understanding of how genetic variations can influence drug response. Her research has led to the development of new strategies for personalized medicine, where treatment plans are tailored to the individual's genetic makeup.

Klein's work on PharmGKB has been particularly influential. This resource provides comprehensive information about the impact of genetic variation on drug response, helping researchers and clinicians to develop more effective and personalized treatment plans.

Awards and Recognition

Throughout her career, Klein has received numerous awards and recognition for her contributions to the field of pharmacogenomics. She is widely regarded as a leading expert in the field and her work has had a significant impact on the development of personalized medicine.

See Also

• Pharmacogenomics
• PharmGKB
• Stanford University
• Personalized Medicine